复发与再感染：艰难梭菌感染监测。
Relapse versus reinfection: surveillance of Clostridium difficile infection.
机构信息
Infectious Disease Service, Infection Control, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
出版信息
Clin Infect Dis. 2011 Nov;53(10):1003-6. doi: 10.1093/cid/cir643. Epub 2011 Oct 5.
Abstract
Molecular typing was used to examine surveillance definitions for recurrent Clostridium difficile-associated diarrhea. Among 102 patients, 85 had a second episode within 8 weeks, 88% of which were relapses. Of 49 second episodes occurring after > 8 weeks, 65% were relapses. Categorization of a recurrent episode occurring after >8 weeks as a new infection may misrepresent the majority of episodes for surveillance.
摘要
分子分型被用于检查复发性艰难梭菌相关性腹泻的监测定义。在 102 名患者中，85 名在 8 周内出现第二次发作，其中 88%为复发。在 >8 周后发生的 49 例第二次发作中，65%为复发。将 >8 周后发生的复发性发作归类为新感染可能会对监测中的大多数发作产生误导。
相似文献
1
Relapse versus reinfection: surveillance of Clostridium difficile infection.复发与再感染：艰难梭菌感染监测。
Clin Infect Dis. 2011 Nov;53(10):1003-6. doi: 10.1093/cid/cir643. Epub 2011 Oct 5.
2
Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.复发与再感染： fidaxomicin 或万古霉素治疗后的复发性艰难梭菌感染。
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S104-9. doi: 10.1093/cid/cis357.
3
Association of relapse of Clostridium difficile disease with BI/NAP1/027.艰难梭菌疾病复发与 BI/NAP1/027 的关联。
J Clin Microbiol. 2012 Dec;50(12):4078-82. doi: 10.1128/JCM.02291-12. Epub 2012 Oct 10.
4
Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County.与瑞典县内医院感染传播和复发相关的艰难梭菌菌株的核糖体分型。
APMIS. 2013 Feb;121(2):153-7. doi: 10.1111/j.1600-0463.2012.02950.x. Epub 2012 Jul 25.
5
Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases.对来自单一、复发和再感染病例的艰难梭菌分离株的分子和微生物学特征进行分析。
J Clin Microbiol. 2012 Mar;50(3):915-21. doi: 10.1128/JCM.05588-11. Epub 2012 Jan 11.
6
Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.改良多位点可变数目串联重复分析在医院暴发期间快速鉴定和分型艰难梭菌。
J Clin Microbiol. 2011 May;49(5):1983-6. doi: 10.1128/JCM.02359-10. Epub 2011 Mar 16.
7
Response to "Effect of geographic region and seasonality on Clostridium difficile incidence and hospital mortality".对《地理区域和季节性对艰难梭菌发病率及医院死亡率的影响》的回应
Am J Infect Control. 2015 Dec 1;43(12):1379. doi: 10.1016/j.ajic.2015.07.031. Epub 2015 Aug 29.
8
An Observational Cohort Study of Ribotype 027 and Recurrent Infection.027 型与再感染的观察性队列研究。
mSphere. 2018 May 23;3(3). doi: 10.1128/mSphere.00033-18. eCollection 2018 May-Jun.
9
Utilizing rapid multiple-locus variable-number tandem-repeat analysis typing to aid control of hospital-acquired Clostridium difficile Infection: a multicenter study.利用快速多位点可变串联重复序列分析分型辅助控制医院获得性艰难梭菌感染：一项多中心研究。
J Clin Microbiol. 2012 Oct;50(10):3244-8. doi: 10.1128/JCM.00784-12. Epub 2012 Jul 25.
10
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.对从18例复发性艰难梭菌相关性腹泻病例中分离出的艰难梭菌菌株进行分子分析。
J Clin Microbiol. 2003 Jul;41(7):3413-4. doi: 10.1128/JCM.41.7.3413-3414.2003.
引用本文的文献
1
Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort.艰难梭菌感染首次和第二次复发时进一步复发的危险因素：一项回顾性队列研究。
BMC Infect Dis. 2025 Aug 22;25(1):1057. doi: 10.1186/s12879-025-11495-0.
2
Novel Biomarkers, Including PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection.新型生物标志物，包括 PCR 循环阈值，可预测复发性艰难梭菌感染。
Infect Immun. 2023 Apr 18;91(4):e0009223. doi: 10.1128/iai.00092-23. Epub 2023 Mar 28.
3
Genomic epidemiology and transmission dynamics of recurrent Clostridioides difficile infection in Western Australia.澳大利亚西部复发性艰难梭菌感染的基因组流行病学和传播动态。
Eur J Clin Microbiol Infect Dis. 2023 May;42(5):607-619. doi: 10.1007/s10096-023-04569-x. Epub 2023 Mar 20.
4
Kinetics of polymerase chain reaction positivity in patients with infection.感染患者中聚合酶链反应阳性的动力学
Therap Adv Gastroenterol. 2021 Oct 8;14:17562848211050443. doi: 10.1177/17562848211050443. eCollection 2021.
5
South African Society of Clinical Microbiology infection diagnosis, management and infection prevention and control guideline.南非临床微生物学会感染诊断、管理及感染预防与控制指南。
S Afr J Infect Dis. 2020 Oct 28;35(1):219. doi: 10.4102/sajid.v35i1.219. eCollection 2020.
6
Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy.粪便微生物移植治疗接受化疗的实体瘤患者艰难梭菌感染是安全的。
Dig Dis Sci. 2022 Jun;67(6):2503-2509. doi: 10.1007/s10620-021-07024-z. Epub 2021 Jun 4.
7
() Pacemaker Infection.（）起搏器感染。
Open Forum Infect Dis. 2020 Oct 14;7(12):ofaa487. doi: 10.1093/ofid/ofaa487. eCollection 2020 Dec.
8
Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.抗阿米巴药物二碘羟基喹啉再利用治疗艰难梭菌感染。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.02115-19.
9
Updates in Treatment of Recurrent Infection.复发性感染治疗的进展
J Clin Med Res. 2019 Jul;11(7):465-471. doi: 10.14740/jocmr3854. Epub 2019 Jun 11.
10
Two-year analysis of Clostridium difficile ribotypes associated with increased severity.与严重程度增加相关的艰难梭菌核糖体分型的两年分析。
J Hosp Infect. 2019 Dec;103(4):388-394. doi: 10.1016/j.jhin.2019.06.003. Epub 2019 Jun 18.
本文引用的文献
1
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.艰难梭菌感染治疗期间和治疗后皮肤污染和艰难梭菌环境脱落的持续存在。
Infect Control Hosp Epidemiol. 2010 Jan;31(1):21-7. doi: 10.1086/649016.
2
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.2008年欧洲艰难梭菌PCR核糖体分型027感染的最新情况
Euro Surveill. 2008 Jul 31;13(31):18942.
3
Recommendations for surveillance of Clostridium difficile-associated disease.艰难梭菌相关性疾病监测建议。
Infect Control Hosp Epidemiol. 2007 Feb;28(2):140-5. doi: 10.1086/511798. Epub 2007 Jan 25.
4
An epidemic, toxin gene-variant strain of Clostridium difficile.一种艰难梭菌的流行、毒素基因变异菌株。
N Engl J Med. 2005 Dec 8;353(23):2433-41. doi: 10.1056/NEJMoa051590. Epub 2005 Dec 1.
5
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.魁北克由高毒力菌株引起的疫情期间，医院内艰难梭菌相关疾病所致的死亡率。
CMAJ. 2005 Oct 25;173(9):1037-42. doi: 10.1503/cmaj.050978. Epub 2005 Sep 22.
6
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.对从18例复发性艰难梭菌相关性腹泻病例中分离出的艰难梭菌菌株进行分子分析。
J Clin Microbiol. 2003 Jul;41(7):3413-4. doi: 10.1128/JCM.41.7.3413-3414.2003.
7
Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.暴发性艰难梭菌感染：一种未得到充分认识且导致死亡和并发症不断增加的病因。
Ann Surg. 2002 Mar;235(3):363-72. doi: 10.1097/00000658-200203000-00008.
8
Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea.HIV阳性且反复发生艰难梭菌相关性腹泻患者复发与再感染的分子分析
J Hosp Infect. 2001 Jun;48(2):86-92. doi: 10.1053/jhin.2001.0943.
9
Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.艰难梭菌相关性腹泻复发或再感染的流行病学
J Clin Microbiol. 2000 Jun;38(6):2386-8. doi: 10.1128/JCM.38.6.2386-2388.2000.
10
Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.基于核糖体RNA基因测序开发一种用于艰难梭菌的新型PCR核糖体分型方法。
FEMS Microbiol Lett. 1999 Jun 15;175(2):261-6. doi: 10.1111/j.1574-6968.1999.tb13629.x.
Zotero 插件